comparemela.com
  1. Home
  2. Live Updates
  3. Immunotech Inc - Breaking News

Latest Breaking News On - Immunotech inc - Page 9 : comparemela.com

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJenene thomasThomask equelsImmunotech incMedinvest biotechPharma investorChief executive officerPharma investor conference

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma

Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET.

New yorkUnited statesThomask equelsImmunotech incChief executive officerMedinvest biotechPharma investor conferenceNyse aimAim immunotech incImmuno oncologyBreast cancerPancreatic cancerOvarian cancerCovid 19Long covid

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023

OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will.

United statesChristopher mcaleerThomask equelsImmunotech incChief executive officer thomasScientific officer christopher mcaleerTech conferenceNyse aimAim immunotech incImmuno oncologyCovid 19Long covid

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

OCALA, Fla., March 26, 2024 AIM ImmunoTech Inc.   announced today that management will host a conference call and webcast to discuss the Company’s Q4/FY2023 operational and financial results.

United statesChristopher mcaleerThomask equelsImmunotech incChief executive officer thomasScientific officer christopher mcaleerTech conference

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through AmpligenOCALA, Fla., March 25, 2024 AIM ImmunoTech Inc.   today announced the.

United statesThomask equelsExchange commissionImmunotech incErasmus university medical centerEarly access programClinical cancer researchAdvanced pancreatic cancerAnti tumor immunityDendritic cell mediatedt responsesExecutive officer thomasPancreato biliary surgeonPrivate securities litigation reform act

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.